[Subarachnoid administration of tetraphan in particularly severe cases of Guillain-Barré syndrome].
D000166:Acridines / Q000627:therapeutic use*; D004396:Coloring Agents / Q000627:therapeutic use*; D020275:Guillain-Barre Syndrome / Q000628:therapy*; D006801:Humans; D006841:Hydrocarbons, Aromatic; D009281:Naphthalenes / Q000031:analogs & derivatives
D000166:Acridines; D004396:Coloring Agents; D006841:Hydrocarbons, Aromatic; D009281:Naphthalenes; C031721:naphthalene
ACRIDINE DYES/therapeutic use; GUILLAIN-BARRE SYNDROME/therapy; NAPHTHALENE/derivatives
Ulteriore contributo all'uso del tetrophan per via sub-aracnoidea in sindromi di Guillain-Barré particolarmente gravi.